Bicara Therapeutics Inc. Liquidation Value
BCAX
Other
Cash & Equivalents
$96.69M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $96.69M
Total Obligations: -$30.66M
$66.03M
Per share: $1.17
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $96.69M
AR: $0
Total Obligations: -$30.66M
$66.03M
Per share: $1.17
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $96.69M
AR: $0
Inventory: $0
Total Obligations: -$30.66M
$66.03M
Per share: $1.17
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $66.03M | $1.17 |
| Liquid Liquidation Value | $66.03M | $1.17 |
| Operating Liquidation Value | $66.03M | $1.17 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $96.69M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $28.95M |
| Long-term Debt | N/A |
| Op. Lease Liability | $1.71M |
| Finance Lease | N/A |
| Shares Outstanding | 56.6M |
Explore all 139 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $96.69M | N/A | N/A | N/A | $28.95M | N/A | $1.71M | N/A |
| 2025-09-30 | $171.67M | N/A | N/A | N/A | $21.03M | N/A | $1.98M | N/A |
| 2025-06-30 | $436.61M | N/A | N/A | N/A | $17.23M | N/A | $2.24M | N/A |
| 2025-03-31 | $462.06M | N/A | N/A | N/A | $19.12M | N/A | $591,000 | N/A |
| 2024-12-31 | $489.71M | N/A | N/A | N/A | $17.99M | N/A | $738,000 | N/A |
| 2024-09-30 | $520.76M | N/A | N/A | N/A | $14.48M | N/A | $445,000 | N/A |
| 2024-06-30 | $203.85M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024-03-31 | $216.05M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
▼ Community Notes